RecallRadar

FDA Drug recall D-1446-2016

buPROPion Hydrochloride Extended Release Tablets USP (SR) 150 mg Rx Only 60 tablets Distributed by Sun Pharmaceutical Industries, Inc

On 2016-07-27 the FDA classified a Class III recall of buPROPion Hydrochloride Extended Release Tablets USP (SR) 150 mg Rx Only 60 tablets Distributed by Sun Pharmaceutical Industries, Inc by Sun Pharmaceutical Industries, citing failed Dissolution Specifications.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1446-2016
ClassificationClass III
Statusterminated
Initiated2016-06-27
Published2016-07-27
Last updated2026-09-13 11:51 UTC
CompanySun Pharmaceutical Industries
DistributionUS

Product

buPROPion Hydrochloride Extended Release Tablets USP (SR) 150 mg Rx Only 60 tablets Distributed by Sun Pharmaceutical Industries, Inc. Cranbury, NJ 08512, Manufactured by: Sun Pharmaceutical Ind. Ltd., Halol-Baroda Highway, Halol 389-350 Gujarat India ---- NDC 47335-737-86

Reason

Failed Dissolution Specifications

Identifiers

ndc47335-736-86
ndc47335-736-88
ndc47335-736-08
ndc47335-736-13
ndc47335-737-86
ndc47335-737-88
ndc47335-737-08
ndc47335-737-13
ndc47335-738-86
ndc47335-738-88
ndc47335-738-08
ndc47335-738-13
code_infoLot JKN3477A, exp 07/2016

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1446-2016%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.